High-level interactions between China and the United States have increased in recent months, fostering a warmer atmosphere. New dialogue mechanisms and communication channels have been established, ...

Anthropic is urging its rivals to pursue an unprecedented regime of AI arms control. The explosive advances in the company’s ...

Anthropic recursive self improvement, Brian Patrick Green tech ethics, AI regulation slowdown, Pope Leo XIV AI encyclical, ...

A Catholic expert on artificial intelligence is commending recent calls by AI research firm Anthropic to rein in the technology amid a significant acceleration in its growth.

Abstract: Recursive multipliers (RMs) have been classified as a class of low-power multipliers because they provide a wide-range of power-quality configuration options. 2×2 multipliers are the ...

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Anthropic now reports that Claude writes more than 80% of the code it ships. The figures that read as a safety warning also describe a business whose output scales with compute rather than headcount.

Abstract: The performance of model predictive controllers (MPC) strongly depends on the quality of their models. In the field of electric drive control, white-box (WB) modeling approaches derived from ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...